MindBio Therapeutics Corp.
MBIO
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -41.58% | -78.17% | -58.39% | -- | -- |
| Total Receivables | 93.55% | 123.89% | 2.78% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -12.64% | -57.75% | -71.06% | -- | -- |
|
|
|||||
| Total Current Assets | -12.64% | -57.75% | -71.06% | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -12.64% | -57.75% | -71.06% | -- | -- |
|
|
|||||
| Total Accounts Payable | 32.25% | 60.11% | -7.59% | -- | -- |
| Total Accrued Expenses | 63.91% | -24.39% | -2.20% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 333.28% | 145.55% | 133.49% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 237.47% | 116.07% | 92.85% | -- | -- |
|
|
|||||
| Total Current Liabilities | 237.47% | 116.07% | 92.85% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -19.49% | -4.69% | -11.03% | -- | -- |
| Total Liabilities | -5.36% | 6.59% | -2.28% | -- | -- |
|
|
|||||
| Common Stock & APIC | -3.62% | 9.68% | 2.33% | -- | -- |
| Retained Earnings | 5.55% | -8.91% | -3.29% | -- | -- |
| Treasury Stock & Other | -13.56% | 2.94% | -3.95% | -- | -- |
| Total Common Equity | 5.05% | -9.93% | -6.49% | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.05% | -9.93% | -6.49% | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 16.71% | 8.71% | 13.56% | -- | -- |
| Total Equity | 5.17% | -9.72% | -6.26% | -- | -- |
|
|
|||||
